Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00250848 · ClinicalTrials.gov registry record
Lung Cancer Case Registry and Tissue Resource
A clinical trial, sponsored by University of New Mexico.
- Terminated
- Registry status
- 750
- Enrollment target
NCT00250848: Clinical Trial study, sponsored by University of New Mexico.
NCT00250848 is a clinical trial that was terminated before completion, run by University of New Mexico. The registered enrollment target is 750 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00250848 was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- 750 participants
- Enrollment target
Study Summary
Potential participants in the Lung Cancer Case Registry will be all patients diagnosed or evaluated for possible treatment of lung cancer at the Cancer Research and Treatment Center (CRTC) and New Mexico Veterans Health Care System (NMVHCS).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2004-03 |
| Est. Completion | 2016-06 |
Why NCT00250848 stopped before completion
NCT00250848 is an observational study that tracks outcomes without assigning an intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00250848 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00250848 about?
NCT00250848 is a clinical study titled "Lung Cancer Case Registry and Tissue Resource". Potential participants in the Lung Cancer Case Registry will be all patients diagnosed or evaluated for possible treatment of lung cancer at the Cancer Research and Treatment Center (CRTC) and New Mexico Veterans Health Care System (NMVHCS).
What is the current status of trial NCT00250848?
This trial is currently terminated. The enrollment target is 750 participants. The study started on 2004-03. Estimated completion is 2016-06.
Who is sponsoring clinical trial NCT00250848?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia